Impact of disease duration and β-cell reserve on the efficacy of switching to iGlarLixi in adults with type 2 diabetes on GLP-1 receptor agonist therapy: Exploratory analyses from the LixiLan-G trial
| Image |  |
|---|---|
| Description | scientific article published on 23 April 2020 |
| Author/s |
author: Stefano Del Prato Juan Frias Vanita R Aroda Lawrence Blonde Julio Rosenstock |
| Publication date | April 23, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |